"On the basis of the BMO report, a case was filed under the 105 BNS, 276 BNS, and 27 (A) Drug and Cosmetic Act. Dr Praveen Soni treated the maximum number of children in this matter. He had prescribed Coldrif... Based on this, he has been named an accused in this case. The manufacturing c
Several children have died after consuming Coldrif cough syrup in Madhya Pradesh, Rajasthan, and Maharashtra, prompting other states like Kerala and Telangana to issue public alerts banning the syrup.
"If Trump's ire is on the trade surpluses, it should actually be directed at China, not at India. India is a sideshow for all these, and it probably got activated due to personal egoistic reasons, on the Nobel Prize or the ceasefire. So we were in a very strange situation", the professor
Through Vibrant Gujarat Regional Conferences initiative, the state government is showcasing how a visionary leader like U.N. Mehta can transform regional economies and foster inclusive growth through hard work and determination.
The probe was initiated after Madhya Pradesh State Food and Drug Controller Dinesh Kumar Maurya requested the Tamil Nadu State Drug Control Department to inspect and take action against the Srisan Pharmaceutical Factory located in Kancheepuram.
The death toll of children in the suspected cough syrup consumption case in Madhya Pradesh's Chhindwara district has risen to nine, said Dr Pawan Nandurkar, Associate Professor and Head of Paediatrics at Nagpur Medical College.
Samples of a cough syrup linked to the deaths of several children have been collected from a pharmaceutical unit in Jabalpur on Friday and are sent for laboratory testing, said Drug Inspector Sharad Kumar Jain.
South Korean shipping stocks fell on Tuesday as investors fretted over a prolonged global trade slowdown tied to U.S. tariff policies, while Hanmi Pharmaceutical rose after announcing a technology transfer deal with Gilead Sciences, the Pulse, the English service of Maeil Business Newspaper
Pune (Maharashtra) [India], September 29: Since its launch in August 2023, the Bajaj Finserv Flexi Cap Fund has grown steadily, reaching Assets Under Management (AUM) of Rs. 5,410.04 crore as of August 31, 2025. The fund has delivered a Compound Annual Growth Rate (CAGR) of 19.19%* under the
Pune (Maharashtra) [India], September 29: Investors often look for ways to participate in sectors that may offer long-term growth potential. A healthcare fund may provide exposure to companies in the healthcare industry, including pharmaceuticals, hospitals, and biotechnology firms.
The Ministry of External Affairs stated on Friday that India is closely monitoring the impact of US President Donald Trump's announcement to impose tariffs of up to 100% on imports of branded and patented pharmaceutical drugs, effective from October 1, 2025.